ASHENEWS reports that the National Agency for Food and Drugs Administration and Control (NAFDAC) has issued a public alert over the circulation of two counterfeit batches of Avastin 400mg/16ml, an anticancer medication manufactured by Roche Diagnostics GmbH, Germany.
Trending
- GSMA warns delays on 6GHz spectrum stall networks
- Patients allege cash-only payments in FCT hospitals
- Ugwu calls for community adoption of health facilities
- Enang calls for sweeping healthcare reforms
- NiMet forecasts rains, thunderstorms Nationwide
- NSN 23rd Conference brings global experts to Abuja on AI, brain tech and African neuroscience
- Jos priest urges regular tree planting
- Fuel price surge challenges clean energy transition in Lagos
